Biomarkers for CNS involvement in pediatric lupus

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

CNS disease, or central neuropsychiatric lupus erythematosus (cNPSLE), occurs frequently in pediatric lupus, leading to significant morbidity and poor long-term outcomes. Diagnosing cNPSLE is especially difficult in pediatrics; many current diagnostic tools are invasive and/or costly, and there are no current accepted screening mechanisms. The most complicated aspect of diagnosis is differentiating primary disease from other etiologies; research to discover new biomarkers is attempting to address this dilemma. With many mechanisms involved in the pathogenesis of cNPSLE, biomarker profiles across several modalities (molecular, psychometric and neuroimaging) will need to be used. For the care of children with lupus, the challenge will be to develop biomarkers that are accessible by noninvasive measures and reliable in a pediatric population.

Original languageEnglish (US)
Pages (from-to)545-558
Number of pages14
JournalBiomarkers in Medicine
Volume9
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Pediatrics
Biomarkers
Neuroimaging
Central Nervous System Diseases
Child Care
Psychometrics
Screening
Morbidity
Research
Population

Keywords

  • biomarkers
  • CNS
  • neuropsychiatric
  • pediatric
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Biomarkers for CNS involvement in pediatric lupus. / Rubinstein, Tamar; Putterman, Chaim; Goilav, Beatrice.

In: Biomarkers in Medicine, Vol. 9, No. 6, 01.06.2015, p. 545-558.

Research output: Contribution to journalArticle

@article{8722dbb55a474f98a7a6ceaa4a18f5df,
title = "Biomarkers for CNS involvement in pediatric lupus",
abstract = "CNS disease, or central neuropsychiatric lupus erythematosus (cNPSLE), occurs frequently in pediatric lupus, leading to significant morbidity and poor long-term outcomes. Diagnosing cNPSLE is especially difficult in pediatrics; many current diagnostic tools are invasive and/or costly, and there are no current accepted screening mechanisms. The most complicated aspect of diagnosis is differentiating primary disease from other etiologies; research to discover new biomarkers is attempting to address this dilemma. With many mechanisms involved in the pathogenesis of cNPSLE, biomarker profiles across several modalities (molecular, psychometric and neuroimaging) will need to be used. For the care of children with lupus, the challenge will be to develop biomarkers that are accessible by noninvasive measures and reliable in a pediatric population.",
keywords = "biomarkers, CNS, neuropsychiatric, pediatric, systemic lupus erythematosus",
author = "Tamar Rubinstein and Chaim Putterman and Beatrice Goilav",
year = "2015",
month = "6",
day = "1",
doi = "10.2217/bmm.15.26",
language = "English (US)",
volume = "9",
pages = "545--558",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Biomarkers for CNS involvement in pediatric lupus

AU - Rubinstein, Tamar

AU - Putterman, Chaim

AU - Goilav, Beatrice

PY - 2015/6/1

Y1 - 2015/6/1

N2 - CNS disease, or central neuropsychiatric lupus erythematosus (cNPSLE), occurs frequently in pediatric lupus, leading to significant morbidity and poor long-term outcomes. Diagnosing cNPSLE is especially difficult in pediatrics; many current diagnostic tools are invasive and/or costly, and there are no current accepted screening mechanisms. The most complicated aspect of diagnosis is differentiating primary disease from other etiologies; research to discover new biomarkers is attempting to address this dilemma. With many mechanisms involved in the pathogenesis of cNPSLE, biomarker profiles across several modalities (molecular, psychometric and neuroimaging) will need to be used. For the care of children with lupus, the challenge will be to develop biomarkers that are accessible by noninvasive measures and reliable in a pediatric population.

AB - CNS disease, or central neuropsychiatric lupus erythematosus (cNPSLE), occurs frequently in pediatric lupus, leading to significant morbidity and poor long-term outcomes. Diagnosing cNPSLE is especially difficult in pediatrics; many current diagnostic tools are invasive and/or costly, and there are no current accepted screening mechanisms. The most complicated aspect of diagnosis is differentiating primary disease from other etiologies; research to discover new biomarkers is attempting to address this dilemma. With many mechanisms involved in the pathogenesis of cNPSLE, biomarker profiles across several modalities (molecular, psychometric and neuroimaging) will need to be used. For the care of children with lupus, the challenge will be to develop biomarkers that are accessible by noninvasive measures and reliable in a pediatric population.

KW - biomarkers

KW - CNS

KW - neuropsychiatric

KW - pediatric

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=84931307705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931307705&partnerID=8YFLogxK

U2 - 10.2217/bmm.15.26

DO - 10.2217/bmm.15.26

M3 - Article

C2 - 26079959

AN - SCOPUS:84931307705

VL - 9

SP - 545

EP - 558

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 6

ER -